Advertisement

Topics

Latest "IN VITRO DIAGNÓSTICA S/A" News Stories

08:14 EST 19th November 2018 | BioPortfolio

Here are the most relevant search results for "IN VITRO DIAGNÓSTICA S/A" found in our extensive news archives from over 250 global news sources.

More Information about IN VITRO DIAGNÓSTICA S/A on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about IN VITRO DIAGNÓSTICA S/A for you to read. Along with our medical data and news we also list IN VITRO DIAGNÓSTICA S/A Clinical Trials, which are updated daily. BioPortfolio also has a large database of IN VITRO DIAGNÓSTICA S/A Companies for you to search.

Showing "VITRO DIAGN STICA" News Articles 1–25 of 1,000+

Sunday 18th November 2018

Access Bio Inc 950130 Product Pipeline Analysis, 2018 Update [Report Updated: 16082018] Prices from USD $750

SummaryAccess Bio Inc Access Bio is a medical device company that research, develops, manufactures and markets invitro diagnostics tests, biosensor, and molecular diagnostic products. The company provides in vitro diagnostic technology such as immunochemical, biochemical and molecular products. It utilizes advanced lateral flow technology for the production of its point of care diagnostic products...


Saturday 17th November 2018

Lumosa Therapeutics Co Ltd 6535 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryLumosa Therapeutics Co Ltd Lumosa Therapeutics is a developer of drugs for the treatment of neurological and inflammatory diseases. The company's pipeline products include LT1001, an analgesic injection for severe pain relief; and LT3001, a novel small molecule for acute ischemic stroke. Its activities comprise chemical development, translational research, preclinical, intellectual property...

Shanghai Kehua Bioengineering Co Ltd 002022 Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryShanghai Kehua Bioengineering Co Ltd KHB is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company's major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte a...


Friday 16th November 2018

Declaración actualizada del Consejo de Promoción Turística de Quintana Roo sobre Taylor Meyer

QUINTANA ROO, Mexico, 16 de noviembre de 2018 /PRNewswire/ -- El Gobierno del Estado de Quintana Roo ha estado en contacto con el Consulado de Read more...

Agilent Expands Cell Analysis R&D Capabilities in Ireland

New facility incorporates recently acquired Luxcel Biosciences Agilent Technologies Inc. (NYSE: A) today announced the opening of a new, purpose-built extension to its Little Island, Cork facility in Ireland. The campus will focus on developing advanced technologies for the analysis of live-cells in real-time. The expanded state-of-the-...

Thursday 15th November 2018

Medical News Today: Dandelion tea benefits

Dandelion tea offers potential health benefits, such as reducing inflammation, improving cholesterol levels, and fighting flu. Most of the research is in vitro or uses animals, so more studies are necessary to confirm its effectiveness in humans. Learn more about the possible health benefits of dandelion tea here.

Banyan Biomarkers Inc Medical Equipment Deals and Alliances Profile [Report Updated: 15102018] Prices from USD $250

SummaryBanyan Biomarkers Inc Banyan Biomarkers is a medical technology company that commercializes vitro diagnostic tests for the detection of traumatic brain injury and neurological diseases. The company's product pipeline includes biomarkers for depression, hypoxic ischemic encephalopathy, neuro ICU monitoring, sub acute or chronic traumatic brain injury, and stroke. Its biomarker includes cellu...

Local activation of mammalian separase in interphase promotes double-strand break repair and prevents oncogenic transformation

Separase halves eukaryotic chromosomes in M-phase by cleaving cohesin complexes holding sister chromatids together. Whether this essential protease functions also in interphase and/or impacts carcinogenesis remains largely unknown. Here, we show that mammalian separase is recruited to DNA double-strand breaks (DSBs) where it is activated to locally cleave cohesin and facilitate homology-directed r...

‘Emotionally, Physically and Financially Distressing’: What Women Are Not Told Before IVF Treatment

(Scroll) – The Delhi resident and her husband, Hemant Gambhir, had taken a chance on in vitro fertilisation or IVF treatment after trying unsuccessfully for five years to have a baby. The couple underwent a battery of tests and investigations. … Read More

TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy

TAIPEI, Taiwan, Nov. 15, 2018 /PRNewswire/ -- TWi Biotechnology, Inc. (TWiB, 6610.TWO), a clinical stage drug development company targeting rare, chronic and inflammatory diseases, announced today that it has completed patient enrollment in its Phase 2 clinical trial (Study code: AC-201CR-HA-001) of AC-201CR for the treatment of hemophilic arthropathy. The Company expects to release top-line resul...

Dynex Technologies Receives CFDA Approval to Supply AGILITY Automated ELISA Processing System to China

Company’s portfolio approval demonstrates dedication to clinical labs in the Asia-Pacific region Dynex® Technologies, Inc., announced today that it received Chinese Food and Drug Administration (CFDA) approval to market its DYNEX AGILITY® instrument and software for quantitative immunoassay measurements of analytes, including proteins and mi...

Assisted reproduction tied to risk of intellectual disabilities in kids

(Reuters Health) - Parents who use reproductive technologies like in vitro fertilization (IVF) may be more likely to have children with intellectual disabilities than those who conceive without help, an Australian study suggests.

Dr. Daniel Kort with Neway Fertility Offers Tips for Cancer Patients

Cancer and Fertility: Preserving Your Options NEW YORK (PRWEB) November 15, 2018 The National Cancer Institute estimates that 1.7 million new cases of cancer will be diagnosed in 2018. While advancing age is the primary risk factor for cancer and we typically associate the disease with old age, about 9 percent of cancers are diagnosed in people under the age of 45. And with aggressive treatment a...

Anthem Blue Cross and Blue Shield Adds Washington County Memorial Hospital to Its Medicare Advantage Provider Network

Anthem and Washington County Memorial Hospital collaborate to increase access to high-quality healthcare Anthem Blue Cross and Blue Shield in Missouri (Anthem) is committed to increasing consumer access to high-quality, affordable healthcare. As part of this commitment, Anthem and Washington County Memorial Hospital (WCMH) announced today that Anthem w...

Visterra Presents Data Demonstrating Safety, Tolerability and Positive Clinical Activity Trends of VIS410 in Non-Hospitalized Patients with Influenza A

Data Demonstrating Reductions in Time to Resolution of Viral Load in Patients and In Vitro Antiviral Activity of VIS410 in Combination with Small Molecule Antivirals Presented at the 6th ISIRV Advances in Respiratory Virus Therapeutics Conference Topline Data from Phase 2b study in Hospitalized Influenza A Patients Requiring Oxygen Support Expecte...

Wednesday 14th November 2018

BTS Research Appoints Mark Crane as Vice President, Business Development

BTS Research, a preclinical services Contract Research Organization, is delighted to announce the addition of

Agilent Completes Acquisition of ACEA Biosciences

Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together two pioneers in cellular function...

ImmunoMolecular Therapeutics Awarded SBIR Grant and Receives Rare Pediatric Disease Designation from FDA for IMT-002

-- SBIR grant awarded to develop D-MDOPA for the preservation of residual beta cell function in type 1 diabetes -- -- Rare Pediatric Disease designation granted to IMT-002 for type 1 diabetes-- ImmunoMolecular

ICON Plc ICLR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryICON plc ICON is a contract research organization CRO that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization...

Synairgen Plc SNG Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummarySynairgen plc Synairgen is a drug discovery and development company, which focuses on the development of novel drugs for the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease COPD. Its pipeline portfolio includes inhaled interferon beta IFN/SNG001 for asthma in Phase II trial; and IFN SNG001 for COPD in Phase I trial. The company develops its drugs b...

Shanghai Kehua Bioengineering Co Ltd 002022 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryShanghai Kehua Bioengineering Co Ltd KHB is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company's major product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits, chemiluminescence reagents; and laboratory instruments such as clinical chemistry analyzers, electrolyte a...

Health Care Equipment Supplies in Europe [Report Updated: 05072018] Prices from USD $350

Health Care Equipment Supplies in EuropeSummaryHealth Care Equipment Supplies in Europe industry profile provides topline qualitative and quantitative summary information including: market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.SynopsisEssential ...

Tuesday 13th November 2018

Two-handed handshake that encourages cell suicide

Researchers have discovered a mechanism that eliminates T cells that pose autoimmune dangers. Although the mechanisms are intertwined with biochemical processes, they also work mechanically, grasping, tugging and clamping, according to Georgia Institute of Technology researchers, who measured responses to physical force acting on these elimination mechanisms. The mechanisms' purpose is to make d...

Anthem Blue Cross and Walmart Collaborate to Give Consumers Increased Access to Everyday Health-Related Products

Anthem will introduce an allowance on some plans and increase it for others for non-prescription medication and health products to create more affordability for consumers Anthem Blue Cross (Anthem) will be working with Walmart to give 2019 Medicare Advantage (MA) plan consumers the ability to purchase over-the-counter (OTC) medications and health-relat...

Charles River Laboratories Continues Commitment to Oncology Drug Discovery

Team of oncology experts expand data in Tumor Model Compendium and present strong portfolio at industry conferences Charles River Laboratories International, Inc. (NYSE: CRL) today announced new additions to the Tumor Model Compendium. Charles River’s Compendium provides access to a comprehensive collection


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks